LFMDP
LifeMD, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$23.50
+0.04%Year over year
Reported trailing growth
- Revenue
- -16.7%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +10.2%
- EBITDA
- +32.5%
- EPS
- +55.4%
Three-year CAGR
- Revenue
- +17.7%
- EBITDA
- +77.2%
- EBIT
- +52.5%
- Net income
- +62.4%
- EPS
- +56.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026